Targeting apoptosis in cancer therapy
BA Carneiro, WS El-Deiry - Nature reviews Clinical oncology, 2020 - nature.com
For over three decades, a mainstay and goal of clinical oncology has been the development
of therapies promoting the effective elimination of cancer cells by apoptosis. This …
of therapies promoting the effective elimination of cancer cells by apoptosis. This …
Mechanism of interaction between autophagy and apoptosis in cancer
The mechanisms of two programmed cell death pathways, autophagy, and apoptosis, are
extensively focused areas of research in the context of cancer. Both the catabolic pathways …
extensively focused areas of research in the context of cancer. Both the catabolic pathways …
Targeting apoptosis in cancer
P Singh, B Lim - Current oncology reports, 2022 - Springer
Abstract Purpose of Review Apoptosis is a major mechanism of cancer cell death. Thus,
evasion of apoptosis results in therapy resistance. Here, we review apoptosis modulators in …
evasion of apoptosis results in therapy resistance. Here, we review apoptosis modulators in …
[HTML][HTML] Targeting apoptotic caspases in cancer
A Boice, L Bouchier-Hayes - … et Biophysica Acta (BBA)-Molecular Cell …, 2020 - Elsevier
Members of the caspase family of proteases play essential roles in the initiation and
execution of apoptosis. These caspases are divided into two groups: the initiator caspases …
execution of apoptosis. These caspases are divided into two groups: the initiator caspases …
Ubiquitin ligases in oncogenic transformation and cancer therapy
The cellular response to external stress signals and DNA damage depends on the activity of
ubiquitin ligases (E3s), which regulate numerous cellular processes, including homeostasis …
ubiquitin ligases (E3s), which regulate numerous cellular processes, including homeostasis …
Small-molecule inhibitors of protein-protein interactions: progressing toward the reality
The past 20 years have seen many advances in our understanding of protein-protein
interactions (PPIs) and how to target them with small-molecule therapeutics. In 2004, we …
interactions (PPIs) and how to target them with small-molecule therapeutics. In 2004, we …
Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity
O Dufva, J Koski, P Maliniemi, A Ianevski… - Blood, The Journal …, 2020 - ashpublications.org
Chimeric antigen receptor (CAR) T-cell therapy has proven effective in relapsed and
refractory B-cell malignancies, but resistance and relapses still occur. Better understanding …
refractory B-cell malignancies, but resistance and relapses still occur. Better understanding …
The roles of E3 ubiquitin ligases in cancer progression and targeted therapy
C Sampson, Q Wang, W Otkur, H Zhao… - Clinical and …, 2023 - Wiley Online Library
Ubiquitination is one of the most important post‐translational modifications which plays a
significant role in conserving the homeostasis of cellular proteins. In the ubiquitination …
significant role in conserving the homeostasis of cellular proteins. In the ubiquitination …
A review of the current impact of inhibitors of apoptosis proteins and their repression in cancer
Simple Summary The Inhibitor of Apoptosis (IAP) family of proteins has emerged as a
potential pharmacological target in cancer. Abnormal expression of IAPs can lead to …
potential pharmacological target in cancer. Abnormal expression of IAPs can lead to …
[HTML][HTML] Macrophage and neutrophil death programs differentially confer resistance to tuberculosis
MD Stutz, CC Allison, S Ojaimi, SP Preston… - Immunity, 2021 - cell.com
Apoptosis can potently defend against intracellular pathogens by directly killing microbes
and eliminating their replicative niche. However, the reported ability of Mycobacterium …
and eliminating their replicative niche. However, the reported ability of Mycobacterium …